Related Experiment Videos
Further studies on complementation between mutants of Clostridium perfringens
Biken Journal
|June 1, 1981
Summary
Clostridium perfringens mutants lacking specific toxins and hemagglutinin were studied. Group B mutants showed defects in multiple toxin and hemagglutinin productions, suggesting shared regulatory pathways.
Area of Science:
- Microbiology
- Bacterial Genetics
Background:
- Clostridium perfringens produces various toxins and hemagglutinin (HA), crucial virulence factors.
- Genetic regulation of these factors is not fully understood.
Purpose of the Study:
- To investigate the genetic basis of toxin and HA production in Clostridium perfringens.
- To characterize mutants deficient in theta-, lambda-, kappa-toxin, and HA.
Main Methods:
- Isolation and complementation analysis of Clostridium perfringens mutants.
- Biochemical assays for toxin activity and extracellular enzyme production.
- Comparison of wild-type and mutant strains (PB6K and CN3870).
Main Results:
- Mutants were classified into complementation groups A and B for lambda- and HA-deficient strains; kappa-deficient mutants belonged to group A.
- Group B mutants exhibited pleiotropic defects in theta-, lambda-, kappa-toxin, and HA production.
- Lambda-toxin was identified as a rennet-like protease.
- Extracellular enzyme activities (including sialidase) were similar between group B mutants and wild-type strains, indicating separate regulatory mechanisms.
Conclusions:
- Shared regulatory mechanisms control the production of theta-, lambda-, kappa-toxin, and HA in Clostridium perfringens.
- These regulatory mechanisms are distinct from those governing the production of other extracellular enzymes.